DK1073438T3 - 8-chlor-6,11-dihydro-11-(4-piperodyliden)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin orale præparater - Google Patents

8-chlor-6,11-dihydro-11-(4-piperodyliden)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin orale præparater

Info

Publication number
DK1073438T3
DK1073438T3 DK99933484T DK99933484T DK1073438T3 DK 1073438 T3 DK1073438 T3 DK 1073438T3 DK 99933484 T DK99933484 T DK 99933484T DK 99933484 T DK99933484 T DK 99933484T DK 1073438 T3 DK1073438 T3 DK 1073438T3
Authority
DK
Denmark
Prior art keywords
piperodylidene
cyclohepta
benzo
dihydro
pyridine
Prior art date
Application number
DK99933484T
Other languages
English (en)
Inventor
Jim H Kou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1073438(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1073438T3 publication Critical patent/DK1073438T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99933484T 1998-07-10 1999-07-08 8-chlor-6,11-dihydro-11-(4-piperodyliden)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin orale præparater DK1073438T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10

Publications (1)

Publication Number Publication Date
DK1073438T3 true DK1073438T3 (da) 2004-05-10

Family

ID=22348307

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99933484T DK1073438T3 (da) 1998-07-10 1999-07-08 8-chlor-6,11-dihydro-11-(4-piperodyliden)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin orale præparater
DK03023240T DK1380297T3 (da) 1998-07-10 1999-07-08 Orale sammensætninger med 8-chlor-6,11-dihydro-11(4-piperidyliden)-5H-benzo[5,6]-cyklo-hepta[1,2-b]pyridin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03023240T DK1380297T3 (da) 1998-07-10 1999-07-08 Orale sammensætninger med 8-chlor-6,11-dihydro-11(4-piperidyliden)-5H-benzo[5,6]-cyklo-hepta[1,2-b]pyridin

Country Status (28)

Country Link
EP (3) EP2055303A3 (da)
JP (4) JP3224379B1 (da)
KR (1) KR100420641B1 (da)
CN (1) CN1145485C (da)
AR (4) AR016044A1 (da)
AT (2) ATE262904T1 (da)
AU (1) AU741201B2 (da)
BR (1) BR9910449A (da)
CA (2) CA2325014C (da)
CY (1) CY1109279T1 (da)
CZ (1) CZ300843B6 (da)
DE (2) DE69940932D1 (da)
DK (2) DK1073438T3 (da)
ES (2) ES2214871T3 (da)
HK (1) HK1030361A1 (da)
HU (1) HU228448B1 (da)
ID (1) ID28645A (da)
IL (1) IL139407A0 (da)
MY (1) MY116038A (da)
NO (1) NO331454B1 (da)
NZ (2) NZ512916A (da)
PE (1) PE20000761A1 (da)
PL (1) PL199390B1 (da)
PT (2) PT1380297E (da)
SK (1) SK288240B6 (da)
TW (1) TW575424B (da)
WO (1) WO2000002560A1 (da)
ZA (1) ZA200006224B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) * 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
AP2007003915A0 (en) * 2004-07-16 2007-02-28 Cipla Ltd Anti-histaminic composition
TW200804358A (en) 2006-03-31 2008-01-16 Res Found Itsuu Lab Novel compound having heterocycle
EP2218443B1 (en) 2007-11-21 2014-03-26 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablet
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
ATE525064T1 (de) 2009-07-01 2011-10-15 Tiefenbacher Alfred E Gmbh & Co Kg Pharmazeutische zusammensetzung mit desloratadin
EP2568970B1 (en) 2010-05-10 2018-12-05 Laboratorios Lesvi, S.L. Stable pharmaceutical formulations containing an antihistaminic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570306B2 (en) 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra

Also Published As

Publication number Publication date
NZ507885A (en) 2001-08-31
DE69940932D1 (de) 2009-07-09
CA2325014A1 (en) 2000-01-20
AU741201B2 (en) 2001-11-22
ZA200006224B (en) 2001-11-01
CA2325014C (en) 2002-05-28
CA2377178A1 (en) 2000-01-20
IL139407A0 (en) 2001-11-25
EP2055303A2 (en) 2009-05-06
SK17112000A3 (sk) 2001-12-03
NO331454B1 (no) 2012-01-09
AR021159A1 (es) 2002-06-12
SK288240B6 (sk) 2015-02-03
HU228448B1 (en) 2013-03-28
KR100420641B1 (ko) 2004-03-02
ES2214871T3 (es) 2004-09-16
IL139407A (en) 2001-10-31
ATE262904T1 (de) 2004-04-15
CZ20004056A3 (cs) 2001-03-14
JP2002068983A (ja) 2002-03-08
EP1380297A1 (en) 2004-01-14
DK1380297T3 (da) 2009-08-17
AR016044A1 (es) 2001-06-20
AR021157A2 (es) 2002-06-12
JP2002520285A (ja) 2002-07-09
JP4621082B2 (ja) 2011-01-26
NO20005485L (no) 2001-03-09
MY116038A (en) 2003-10-31
EP1380297B1 (en) 2009-05-27
PT1380297E (pt) 2009-07-06
JP4160739B2 (ja) 2008-10-08
BR9910449A (pt) 2001-01-02
WO2000002560A1 (en) 2000-01-20
EP1073438A1 (en) 2001-02-07
NZ512916A (en) 2003-03-28
ATE432075T1 (de) 2009-06-15
PE20000761A1 (es) 2000-08-31
AR021158A2 (es) 2002-06-12
PL344045A1 (en) 2001-09-24
HUP0101900A3 (en) 2003-01-28
PT1073438E (pt) 2004-07-30
EP1073438B1 (en) 2004-03-31
CN1145485C (zh) 2004-04-14
CZ300843B6 (cs) 2009-08-26
HUP0101900A2 (hu) 2001-11-28
KR20010043402A (ko) 2001-05-25
JP2010265329A (ja) 2010-11-25
JP3224379B1 (ja) 2001-10-29
ES2326214T3 (es) 2009-10-05
CN1303284A (zh) 2001-07-11
JP2005298524A (ja) 2005-10-27
DE69916042T2 (de) 2004-11-11
PL199390B1 (pl) 2008-09-30
EP2055303A3 (en) 2009-12-16
DE69916042D1 (de) 2004-05-06
CY1109279T1 (el) 2012-05-23
AU4953199A (en) 2000-02-01
ID28645A (id) 2001-06-21
TW575424B (en) 2004-02-11
NO20005485D0 (no) 2000-10-31
HK1030361A1 (en) 2001-05-04

Similar Documents

Publication Publication Date Title
LU90738I2 (fr) Desloratadine
NZ222253A (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo c5,6,)cyclohepta c1,2-b)pyridine derivatives and pharmaceutical compositions
NO996547L (no) Polymorfer av 8-klor-6,11-dihydro-11-(4-piperidyliden)-5H- benzo[5,6]syklohepta[1,2-b]pyridin
DK1073438T3 (da) 8-chlor-6,11-dihydro-11-(4-piperodyliden)-5H-benzo[5,6]cyclohepta[1,2-b]pyridin orale præparater
DK1068194T3 (da) PDE IV-hæmmende pyridinderivater
DE60008073D1 (de) Furo[3,2-b]pyridine als 5-ht1f agonisten
DE60001054T2 (de) Trizyclische pyridin n-oxide vasopressin agonisten
AU9683798A (en) Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo{5,6}cyclohepta {1,2-b}pyridin -11-ylidene)-1- piperidene carboxylate polymorph
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions